Skip to main content
Top
Published in: Cancer Causes & Control 11/2019

01-11-2019 | Colonoscopy | Brief report

Post-operative colorectal cancer surveillance: preference for optical colonoscopy over computerized tomographic colonography

Authors: David S. Weinberg, Jeremy Mitnick, Eileen Keenan, Tianyu Li, Eric A. Ross

Published in: Cancer Causes & Control | Issue 11/2019

Login to get access

Abstract

Purpose

Post-operative surveillance strategies for colorectal cancer (CRC) include periodic optical colonoscopy (OC) and abdominal-pelvic CT scan. Adherence with these recommendations is limited. For CRC screening, CT colonography (CTC) identifies larger adenomas and cancers nearly as well as OC. Most screening studies demonstrate that patients prefer CTC. However, CTC has never been compared to OC in the post-operative surveillance setting.

Methods

We hypothesized that CTC might represent an attractive substitute for the standard OC/CT scan combination. Here, 223 patients underwent CTC followed by same day OC 1 year after curative CRC resection.

Results

Of the 144/223 (64.6%) participants with a preference, 65.9% (95/144) preferred OC. This preference was more pronounced in women and in patients with polyps detected. No additional patient level factors significantly altered this primary result.

Conclusions

In contrast to CRC screening, this first study in CRC post-operative surveillance patients demonstrates a preference for OC. Assuming patient preference is an important determinant, introduction of CTC as a method to increase patient adherence with CRC surveillance is unlikely to be effective.

Trial registration

Clinical Trials.gov registration number: NCT02143115.
Literature
1.
go back to reference Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD et al (2013) Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 31(35):4465–4470CrossRefPubMed Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD et al (2013) Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 31(35):4465–4470CrossRefPubMed
2.
go back to reference Benson AB, 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. (2018) NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw 16(4):359–369.CrossRefPubMed Benson AB, 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. (2018) NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw 16(4):359–369.CrossRefPubMed
3.
go back to reference Mollica MA, Enewold LR, Lines LM, Halpern MT, Schumacher JR, Hays RD et al (2017) Examining colorectal cancer survivors' surveillance patterns and experiences of care: a SEER-CAHPS study. Cancer Causes Control 28(10):1133–1141CrossRefPubMed Mollica MA, Enewold LR, Lines LM, Halpern MT, Schumacher JR, Hays RD et al (2017) Examining colorectal cancer survivors' surveillance patterns and experiences of care: a SEER-CAHPS study. Cancer Causes Control 28(10):1133–1141CrossRefPubMed
4.
go back to reference Weinberg DS, Pickhardt PJ, Bruining DH, Edwards K, Fletcher JG, Gollub MJ, et al. (2018) Computed tomography colonography vs colonoscopy for colorectal cancer surveillance after surgery. Gastroenterology 154(4):927–934.CrossRefPubMed Weinberg DS, Pickhardt PJ, Bruining DH, Edwards K, Fletcher JG, Gollub MJ, et al. (2018) Computed tomography colonography vs colonoscopy for colorectal cancer surveillance after surgery. Gastroenterology 154(4):927–934.CrossRefPubMed
5.
go back to reference Lin OS, Kozarek RA, Gluck M, Jiranek GC, Koch J, Kowdley KV et al (2012) Preference for colonoscopy versus computerized tomographic colonography: a systematic review and meta-analysis of observational studies. J Gen Intern Med 27(10):1349–1360CrossRefPubMedPubMedCentral Lin OS, Kozarek RA, Gluck M, Jiranek GC, Koch J, Kowdley KV et al (2012) Preference for colonoscopy versus computerized tomographic colonography: a systematic review and meta-analysis of observational studies. J Gen Intern Med 27(10):1349–1360CrossRefPubMedPubMedCentral
6.
go back to reference Wilson TR, Alexander DJ, Kind P (2006) Measurement of health-related quality of life in the early follow-up of colon and rectal cancer. Dis Colon Rectum 49(11):1692–1702CrossRefPubMed Wilson TR, Alexander DJ, Kind P (2006) Measurement of health-related quality of life in the early follow-up of colon and rectal cancer. Dis Colon Rectum 49(11):1692–1702CrossRefPubMed
7.
8.
go back to reference Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 16(3):566–571CrossRefPubMed Mariotto AB, Rowland JH, Ries LA, Scoppa S, Feuer EJ (2007) Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev 16(3):566–571CrossRefPubMed
9.
go back to reference Jeffery M, Hickey BE, Hider PN, See AM ( 2016) Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 11:CD002200.PubMed Jeffery M, Hickey BE, Hider PN, See AM ( 2016) Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 11:CD002200.PubMed
10.
go back to reference Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K et al (2018) Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA 319(20):2104–2115CrossRefPubMedPubMedCentral Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K et al (2018) Association between intensity of posttreatment surveillance testing and detection of recurrence in patients with colorectal cancer. JAMA 319(20):2104–2115CrossRefPubMedPubMedCentral
11.
go back to reference Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A et al (2014) Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 311(3):263–270CrossRefPubMed Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A et al (2014) Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 311(3):263–270CrossRefPubMed
12.
go back to reference Fichera A (2018) Less is more in colorectal cancer posttreatment surveillance. JAMA Surg 153(10):877CrossRefPubMed Fichera A (2018) Less is more in colorectal cancer posttreatment surveillance. JAMA Surg 153(10):877CrossRefPubMed
13.
go back to reference Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR (2017) Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst 109(2):djw205.CrossRefPubMed Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR (2017) Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst 109(2):djw205.CrossRefPubMed
14.
go back to reference Howard K, Salkeld G, Pignone M, Hewett P, Cheung P, Olsen J et al (2011) Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment. Value Health 14(8):1146–1152CrossRefPubMedPubMedCentral Howard K, Salkeld G, Pignone M, Hewett P, Cheung P, Olsen J et al (2011) Preferences for CT colonography and colonoscopy as diagnostic tests for colorectal cancer: a discrete choice experiment. Value Health 14(8):1146–1152CrossRefPubMedPubMedCentral
Metadata
Title
Post-operative colorectal cancer surveillance: preference for optical colonoscopy over computerized tomographic colonography
Authors
David S. Weinberg
Jeremy Mitnick
Eileen Keenan
Tianyu Li
Eric A. Ross
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 11/2019
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-019-01231-w

Other articles of this Issue 11/2019

Cancer Causes & Control 11/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine